Neurology
1 drug is in development for Neuromuscular Diseases.
- Companies
- 1
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Neuromuscular Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| nexiguran ziclumeran | Intellia Therapeutics, Inc. (NTLA) |
About this indication
Neuromuscular Diseases context
Neurology·MeSH: Neuromuscular Diseases (D009468)
Also known as: Neuromuscular Disease
Frequently asked questions
How many drugs are in development for Neuromuscular Diseases?
BioSniper tracks 1 drug in development for Neuromuscular Diseases across 1 company.
How many clinical trials target Neuromuscular Diseases?
There are 9 clinical trials targeting Neuromuscular Diseases tracked by BioSniper.